119
Views
2
CrossRef citations to date
0
Altmetric
Letters

A case of inclusion body myositis complicated by microscopic polyangiitis

, , , , , , , , , & show all
Pages 243-245 | Accepted 22 May 2017, Published online: 20 Jul 2017

References

  • Rose MR; ENMC IBM Working Group. 188th ENMC international workshop: inclusion body myositis, 2–4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 2013;23:1044–55.
  • Pluk H, van Hoeve BJ, van Dooren SH, Stammen-Vogelzangs J, van der Heijden A, Schelhaas HJ, et al. Autoantibodies to cytosolic 5ʹ-nucleotidase 1A in inclusion body myositis. Ann Neurol 2013;73:397–407.
  • Greenberg SA. Cytoplasmic 5ʹ-nucleotidase autoantibodies in inclusion body myositis: isotypes and diagnostic utility. Muscle Nerve 2014;50:488–92.
  • Brady S, Squier W, Sewry C, Hanna M, Hilton-Jones D, Holton JL. A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open 2014;4:e004552.
  • Herbert MK, Stammen-Vogelzangs J, Verbeek MM, Rietveld A, Lundberg IE, Chinoy H, et al. Disease specificity of autoantibodies to cytosolic 5ʹ-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases. Ann Rheum Dis 2016;75:696–701.
  • Dimachkie MM, Barohn RJ. Inclusion body myositis. Semin Neurol 2012;32:237–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.